Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China
· Delayed Price · Currency is CNY 26.65
-0.53 (-1.95%)
Apr 29, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Company Description
Wuhan Hvsen Biotechnology Co.,Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally.
The company offers tylvalosin tartrate powders and raw materials; florfenicol, cefquinome sulfate, and tildipirosin injections; and florfenicol powder/WSP, tylosin tartrate soluble powder, and tywasin premix products.
It produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives.
Hvsen Biotechnology Co., Ltd. was founded in 2002 and is based in Wuhan, China.
Wuhan Hvsen Biotechnology Co.,Ltd.
| Country | China |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,028 |
| CEO | Jie Han |
Contact Details
Address: No. 1, Zhonghua Road Wuhan, 430060 China | |
| Phone | 86 27 8860 5516 |
| Website | whhsyy.com |
Stock Details
| Ticker Symbol | 300871 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000047H6 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jie Han | Rotating General Manager |
| Kaijie Yang | Deputy GM and Chief Financial Officer |
| Zexiang Liu | Director and Assistant to the GM |
| Qingfeng Wang | Board Secretary |
| Jinbin Huang | Deputy General Manager |
| Shuo Li | Deputy General Manager |
| Hujie Yu | Deputy General Manager |
| Qiongbi Luo | Accounting Supervisor |
| Hongxia Li | Director of Warehousing and Logistics Data and Supervisor |
| Wenge Ding | Product and Technical Service Director and Supervisor |